Evidence for basolateral uptake of cadmium in the kidneys of rats

Toxicology and Applied Pharmacology

Volumn 164, Issue 1, 2000, Pages 15-23

  Zalups, Rudolfs K ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADMIUM; CADMIUM CHLORIDE; CYSTEINE; GLUTATHIONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOLATERAL MEMBRANE; BIOACCUMULATION; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; MALE; NONHUMAN; RAT; REACTION ANALYSIS; TISSUE LEVEL; TOXICOKINETICS; TRANSPORT KINETICS; URETER LIGATION;

ANIMALIA;

EID: 0034176481     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8854     Document Type: Article

References (29)

1. 1). Toxicol. In Vitro. 6:1992;195-200.
2. Cain K., Holt D. E. Studies of cadmium-thionein induced nephropathy: Time course of cadmium-thionein uptake and degradation. Chem.-Biol. Interact. 43:1983;223-237.
3. Cherian M. G., Goyer R. A., Delaquerriere-Richardson L. Cadmium metallothionein induced nephropathy. Toxicol. Appl. Pharmacol. 38:1976;399-408.
4. Diamond G. L., Cohen J. J., Weinstein S. L. Renal handling of cadmium in perfused rat kidney and effects on renal function and tissue composition. Am. J. Physiol. 251:1986;F784-F794.
5. Diamond G. L., Zalups R. K. Understanding renal toxicity of heavy metals. Toxicol. Pathol. 26:1998;92-103.
6. Felley-Bosco E., Diezi J. Fate of cadmium in rat renal tubule: A microinjection study. Toxicol. Appl. Pharmacol. 91:1987;204-211.
7. Felley-Bosco E., Diezi J. Fate of cadmium in rat renal tubule: A micropuncture study. Toxicol. Appl. Pharmacol. 98:1989;243-251.
8. Foulkes E. C. Excretion and retention of cadmium, zinc, and mercury by rabbit kidney. Am. J. Physiol. 227:1974;1356-1360.
9. 1 cells. Toxicol. Appl. Pharmacol. 137:1996;301-306.
10. 1 cells. Toxicol. Appl. Pharmacol. 128:1994;264-270.
11. 2 and CdMT exposure with acute CdMT injection in rats. Toxicol. Appl. Pharmacol. 153:1998;48-58.
12. Maitani T., Cuppage F. E., Klaassen C. D. Nephrotoxicity of intravenously injected cadmium-metallothionein: Critical concentration and tolerance. Fundam. Appl. Toxicol. 10:1988;98-108.
13. Malvin R. L., Wilde W. S. Stop-flow technique. Orloff J., Berliner R. W. Handbook of Physiology. 1973;119-128 American Physiological Society, Washington.
14. Nordberg G. F., Goyer R., Nordberg M. Comparative toxicity of cadmium-metallothionein and cadmium chloride on mouse kidney. Arch. Pathol. 99:1975;192-197.
15. 1 cells on permeable membrane supports. Arch. Toxicol. 67:1993;113-119.
16. 1 cells. Life Sci. 53:1993;337-342.
17. Rabenstein, D. L.1989. Metal complexes of glutathione and their biological significance. In Glutathione: Chemical, Biochemical and Medical Aspects, Vol. 3, Coenzymes and Cofactors (D. Dolphin, O. Auramovibc, and R. Poulson, Eds.), pp. 147-186, Wiley, New York.
18. Robinson M. K., Barfuss D. W., Zalups R. K. Cadmium transport and toxicity in isolated perfused segments of the renal proximal tubule. Toxicol. Appl. Pharmacol. 121:1993;103-111.
19. Squibb K. S., Pritchard J. B., Fowler B. A. Cadmium-metallothionein nephropathy: Relationships between ultrastructure/biochemical alterations and intracellular cadmium binding. J. Pharmacol. Exp. Ther. 229:1984;311-321.
20. Zalups R. K. Organic anion transport and action of γ-glutamyltranspeptidase in kidney linked mechanistically to renal tubular uptake of inorganic mercury. Toxicol. Appl. Pharmacol. 132:1995;289-298.
21. Zalups R. K. Basolateral uptake of inorganic mercury in the kidney. Toxicol. Appl. Pharmacol. 151:1998;192-199.
22. Zalups R. K., Barfuss D. W. Pretreatment with p-aminohippurate inhibits the renal uptake and accumulation of injected inorganic mercury in the rat. Toxicology. 103:1995a;23-35.
23. Zalups R. K., Barfuss D. W. Accumulation and handling of inorganic mercury in the kidney after coadministration with glutathione. J. Toxicol. Environ. Health. 44:1995b;385-399.
24. Zalups R. K., Barfuss D. W. Renal disposition of mercury in rats after intravenous injection of inorganic mercury and cysteine. J. Toxicol. Environ. Health. 44:1995c;401-413.
25. Zalups R. K., Barfuss D. W. Small aliphatic dicarboxylic acids inhibit renal uptake of administered mercury. Toxicol. Appl. Pharmacol. 148:1998a;183-193.
26. Zalups R. K., Barfuss D. W. Participation of mercuric conjugates of cysteine, homocysteine, and N-acetylcysteine in mechanisms involved in the renal tubular uptake of inorganic mercury. J. Am. Soc. Nephrol. 9:1998b;551-561.
27. Zalups R. K., Minor K. H. Luminal and basolateral mechanisms involved in the renal tubular uptake of inorganic mercury. J. Toxicol. Environ. Health. 46:1995;73-100.
28. Zalups R. K., Cherian M. G., Barfuss D. W. Lack of luminal or basolateral uptake and transepithelial transport of mercury in isolated perfused proximal tubules exposed to mercury-metallothionein. J. Toxicol. Environ. Health. 44:1995;401-413.
29. Zalups R. K., Gelein R. M., Cherian M. G. Shifts in the dose-effect relationship for the nephropathy induced by cadmium-metallothionein in rats after a reduction in renal mass. J. Pharmacol. Exp. Ther. 262:1992;1256-1266.